🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pain is one of the most common symptoms associated with malignant tumor. Th...
Status
Terminated
Location
AT004
Start Date
2013-10-29
Trial ID
NCT01964378
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of GRT6005...
Status
Completed
Location
Site 051
Start Date
2012-12-04
Trial ID
NCT01709214
The objective of this study was to evaluate the pharmacokinetics (PK), safe...
Status
Completed
Location
US0001 Contract research organization
Start Date
2013-06-20
Trial ID
NCT03882762
Treatments Being Tested
Opioids are potent painkillers but come with serious adverse effects rangin...
Status
Completed
Location
Centre for Human Drug Research (CHDR)
Start Date
2022-07-29
Trial ID
NCT05491785
The objective of this study was to evaluate the effects of cebranopadol (GR...
Status
Completed
Location
US001 Contract research organization
Start Date
2013-07-10
Trial ID
NCT03958123
This study will be conducted to evaluate the abuse potential of single dose...
Status
Completed
Location
Ohio Clinical Trials
Start Date
2022-03-28
Trial ID
NCT05256108
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Cebrano...
Status
Completed
Location
ALLEVIATE 2 Site 001108
Start Date
2024-07-18
Trial ID
NCT06423703
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Cebrano...
Status
Completed
Location
ALLEVIATE 1 Site 001106
Start Date
2024-09-03
Trial ID
NCT06545097
Treatments Being Tested
The purpose of this trial is to evaluate if cebranopadol is safe and can de...
Status
Completed
Location
US002
Start Date
2013-09-27
Trial ID
NCT01939366
Treatments Being Tested
The primary objective of this study was to evaluate the abuse potential of ...
Status
Completed
Location
INC Research
Start Date
2013-04-15
Trial ID
NCT03757559